DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance (vol 15, 275, 2024)NATURE COMMUNICATIONSIF15.72024-08-190OAAI
Elucidating the cellular responses and mechanism of action of 177Lu-based radioligand therapyCANCER RESEARCHIF16.62024-04-050PRE
DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistanceNATURE COMMUNICATIONSIF15.72024-01-0421OA
A strategy to assess the cellular activity of E3 ligase components against neo-substrates using electrophilic probesCELL CHEMICAL BIOLOGYIF7.22022-01-018OAAI
Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivoNATURE CHEMICAL BIOLOGYIF13.72021-05-1088OAAI
Identification of a potent and selective covalent Pin1 inhibitorNATURE CHEMICAL BIOLOGYIF13.72020-06-0161OAAI
Discovery and characterization of covalent Pin1 inhibitors targeted to an active site cysteineCANCER RESEARCHIF16.62019-07-010PRE
Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cellsNATURE COMMUNICATIONSIF15.72018-08-09138OAAI
A Novel Bifunctional Alkylphenol Anesthetic Allows Characterization of γ-Aminobutyric Acid, Type A (GABAA), Receptor Subunit Binding Selectivity in SynaptosomesJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92016-09-0127OAAI